Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Comparison of the presence of prenatal complications and medication status between the groups

From: Perinatal outcomes and predictors of neonatal mortality in preterm premature rupture of membranes: a tertiary center experience

Variables

Group I (23–27+ 6) (n:19)

Group II (28–31+ 6) (n:30)

Group III (32–33+ 6) (n:41)

Group IV (34–36+ 6) (n:93)

p-value*

Completed antibiotic treatment, (n, %)

10(52.6%)

23(76.7%)

24(58.5%)

13(14.0%)

0.001 [I; II, III- IV]

Chorioamnionitis, (n, %)

2(10.5%)

2(6.7%)

1(2.4%)

2(2.2%)

0.272

Placental Abruption, (n, %)

2(10.5%)

2(6.7%)

-

1(1.1%)

0.062

Fetal Distress, (n, %)

2(10.5%)

4(13.3%)

7(17.1%)

6(6.5%)

0.284

Oligohydramnios, (n, %)

14(73.7%)

13(43.3%)

17(41.5%)

8(8.6%)

0.001 [I, II, III-IV]

Spontaneous labor, (n, %)

15(78.9%)

22(73.3%)

29(70.7%)

68(73.1%)

0.930

Completed Betamethasone treatment, (n, %)

11(57.9%)

23(76.7%)

24(58.5%)

12(12.9%)

0.001 [I, II, III-IV]

Completed Neuroprotection, (n, %)

19(100.0%)

21(70.0%)

2 (4.9%)

-

0.001 [I, II-III] [II, II-IV]

  1. * “Pearson‒χ2 cross tables” were used to examine the relationships between two qualitative variables
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us